The trademark application FIRJOIVA was filed by Bristol-Myers Squibb Company, a U.S. corporation (the "Applicant"). The application was published for oppositions on April 18, 2021, and it was registered by office on July 26, 2021 without any oppositions.
The application was filed in English (French was selected as the second language).